Diana Handke - Concepedia

Author

Diana Handke

Martin Luther University Halle-Wittenberg

Also Known As

D Handke, D. Handke, Diana Handke, Handke Diana

Publications

520

Citations

H-Index

Concepts

All Affiliations

Martin Luther University Halle-Wittenberg Karolinska Institutet University Hospital of Zurich Unfallkrankenhaus Salzburg Luther University

About

Diana Handke is an author at Martin Luther University Halle-Wittenberg specializing in medicine, immunology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	243
2	Cell Biology	3	3	148
3	Immunology	3	3	148
4	Pathology	2	2	149
5	Autoimmunity	1	1	54

Diana Handke

Publications

410

Citations

H-Index

Page 1

	Year	Citations
Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer Barbara Seliger, Robert Stoehr, Diana Handke, Cancer Immunology Immunotherapy HistocompatibilityEarly RecurrenceUrologyGenitourinary CancerMedicine	2009	95
Frequent Loss of HLA-A2 Expression in Metastasizing Ovarian Carcinomas Associated with Genomic Haplotype Loss and HLA-A2-Restricted HER-2/<i>neu</i>-Specific Immunity Håkan Norell, Mattias Carlsten, Tomas Ohlum, Cancer Research	2006	64
T cell recognition of HLA‐A2 restricted tumor antigens is impaired by the oncogene HER2 Kousaku Mimura, Takashi Ando, Isabel Poschke, International Journal of Cancer HlaHistocompatibilityMhc ClassHla ImmunogeneticsImmunology	2010	55
Expression and regulation of non‐classical HLA‐G in renal cell carcinoma K. Dunker, Gerald Schlaf, Juergen Bukur, Tissue Antigens HistocompatibilityRenal PathologyImmunologyPathologyAntigen Processing	2008	54
Identification of E2F1 as an Important Transcription Factor for the Regulation of Tapasin Expression Juergen Bukur, F Herrmann, Diana Handke, Journal of Biological Chemistry Molecular RegulationGeneticsImmunologyImmune RegulationImmunologic Mechanism	2010	39
Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients Maria‐Filothei Lazaridou, Evamaria Gonschorek, Chiara Massa, OncoImmunology	2020	39
Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma Barbara Seliger, Diana Handke, Elisabeth Schabel, Journal of Translational Medicine	2009	28
Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma Maria‐Filothei Lazaridou, Chiara Massa, Diana Handke, Journal of Clinical Medicine	2020	26
Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant Melanoma Stefanie Meyer, Diana Handke, Anja Müeller, Cancers	2021	10

Page 1